Our findings highlight the potential role of genetic polymorphisms in NGF, BDNF, TH, and EPO in modulating the pathophysiology of ROP through their influence on hematological, neurovascular, and inflammatory pathways. The gene discussed is TH; the disease is retinopathy of prematurity.